← Back to Search

Behavioral Intervention

Cognitive Behavioural Therapy for Adolescent Obesity

N/A
Waitlist Available
Research Sponsored by University of Manitoba
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
14-17 years old
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up one week at week 16 and week 32
Awards & highlights

Study Summary

This trial is testing a new therapy to help improve quality of life and weight management in youth at risk for type 2 diabetes.

Who is the study for?
This trial is for adolescents aged 14-17 with obesity, willing to follow study procedures and showing mild-moderate depression. They must not be on certain medications like atypical antipsychotics or steroids, have multiple health issues, a history of self-harm in the last year, currently in psychotherapy/DBT, or have had recent weight loss treatments.Check my eligibility
What is being tested?
The study tests if Dialectical Behavioral Therapy (DBT), which includes mindfulness and stress coping strategies, can improve life quality and help manage weight in youth at risk for type 2 diabetes. Participants will join one of three groups: lifestyle changes plus DBT sessions, just lifestyle changes, or a control group.See study design
What are the potential side effects?
Since this trial involves therapy and lifestyle modifications rather than medication, typical drug side effects are not expected. However, participants may experience emotional discomfort when discussing personal issues during therapy sessions.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 14 and 17 years old.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~one week at week 16 and week 32
This trial's timeline: 3 weeks for screening, Varies for treatment, and one week at week 16 and week 32 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Adherence to the intervention
Enrollment rates
Retention for follow up measurements
Secondary outcome measures
Barriers for lifestyle change
DBT benefits and challenges
DBT skills training
+3 more

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: Lifestyle aloneExperimental Treatment1 Intervention
Participants will receive 2 lifestyle sessions per week, one 90 minutes in length and the other 60 minutes for 16 weeks.
Group II: DBT + lifestyleExperimental Treatment2 Interventions
Participants will receive 90 minutes of dialectical behavioral therapy and 60 minutes of lifestyle sessions each week for 16 weeks.
Group III: ControlActive Control1 Intervention
Participants will be included in baseline, endpoint and follow up measurements, but will receive no form of intervention.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Dialectical behavioral therapy
2019
N/A
~40
Lifestyle
2016
Completed Phase 4
~8600

Find a Location

Who is running the clinical trial?

Diabetes CanadaOTHER
10 Previous Clinical Trials
1,101 Total Patients Enrolled
University of ManitobaLead Sponsor
595 Previous Clinical Trials
199,516 Total Patients Enrolled
Children's Hospital Research Institute of Manitoba (CHRIM)UNKNOWN
1 Previous Clinical Trials
40 Total Patients Enrolled

Media Library

Dialectical Behavioral Therapy (DBT) (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05338944 — N/A
Type 2 Diabetes Research Study Groups: DBT + lifestyle, Lifestyle alone, Control
Type 2 Diabetes Clinical Trial 2023: Dialectical Behavioral Therapy (DBT) Highlights & Side Effects. Trial Name: NCT05338944 — N/A
Dialectical Behavioral Therapy (DBT) (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05338944 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is enrollment currently available for this trial?

"The clinical trial, which was first proposed on January 1st 2023 and last amended October 5th 2022, is actively seeking participants."

Answered by AI

Who qualifies to participate in this clinical experiment?

"This study seeks 15 volunteers between 14 and 17 years old who present with prevention, a BMI z-score greater than 1.6, willingness to commit to the trial's procedures as well as evidence of mild-moderate depression (PHQ-9 score 5-19)."

Answered by AI

How many individuals are currently enrolled in this research endeavor?

"That is accurate. According to the information on clinicaltrials.gov, this research project has been accepting recruits since 1/1/2023 and was most recently updated on 10/5/2022. The trial seeks 15 individuals from a single location."

Answered by AI

Is the minimum age threshold for enrolment into this clinical research 18 years or older?

"The enrollment criteria for this research project allows individuals aged between 14 and 17 to participate. To further contextualize, there are 195 clinical trials available to minors while 1077 have been designed with elderly people in mind."

Answered by AI

What objectives is this clinical trial aiming to accomplish?

"This research study has two primary outcomes that will be assessed over a duration of 32 weeks. These are enrollment rates and patient-centeredness, which is evaluated using focus groups and feedback forms. Secondary objectives include evaluating delivery of the behavioural intervention, barriers for lifestyle change (gathered through photovoice participation at 16 weeks), as well as other mental health co-morbidities related to self-regulation."

Answered by AI
~3 spots leftby Jan 2026